Skip to content

Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke

Mobile Electromyography (EMG)-Driven Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03752775
Enrollment
45
Registered
2018-11-26
Start date
2018-11-01
Completion date
2027-12-31
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Limb Rehabilitation

Keywords

stroke, upper limb, Joint coordination

Brief summary

A new clothing robotic arm was developed for multi-joint coordinated upper limb rehabilitation after stroke. Patients after stroke will be recruited to evaluate the rehabilitation effectiveness of the device assisted upper limb rehabilitation. Both patients with chronic stroke and subacute stroke will be investigated.

Detailed description

A new robotic arm, named mobile exo-neuro-musculo-skeleton, was developed for upper limb rehabilitation. The system integrated the advantages of exoskeleton, soft robot, and neuromuscular electrical stimulation. It is noninvasive, light in weight, comfortable to wear, and can support the motions at the elbow, the wrist and the fingers. The device is a mobile system interfaced with a mobile app by a user. The device assisted upper limb rehabilitation will be applied to inpatients with subacute stroke. The rehabilitation effects on the motor restoration in the upper limb will be compared with the conventional physical and occupational therapies. The rehabilitation effects of the device assisted training also will be evaluated on patients with chronic stroke. The motor improvements after training will be investigated by comparing the pre- and post- clinical assessments. It is hypothesized that the device assisted upper limb rehabilitation will be effective in both subacute and chronic patients.

Interventions

DEVICERobot assisted upper limb rehabilitation

The patients in the experimental and the other arms will receive 20 session device assisted upper limb rehabilitation. In each session, a subject will conduct multi-joint coordinated upper limb motions for 1 hour.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

The device assisted treatment will be administrated to patients with subacute stroke and chronic stroke. The subacute stroke group will be compared in parallel with a control group receive the conventional physical and occupational therapies.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

For the subacute groups: * Two weeks after the onset of stroke, however less than 0.5 year * Mini-Mental State Examination (MMSE)\>21 * Able to sit up for at least 1 hour * Fugl-Meyer Assessment (FMA) upper limb \<30 * Modified Ashworth Score (MAS) at the elbow, wrist and fingers \<3 * Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline) For the chronic device assisted group: * At least 0.5 year after the onset of stroke * Mini-Mental State Examination (MMSE)\>21 * Able to sit up for at least 1 hour * Fugl-Meyer Assessment (FMA) upper limb \<30 * Modified Ashworth Score (MAS) at the elbow, wrist and fingers \<3 * Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline)

Exclusion criteria

Subjects will be excluded if they do not meet the above inclusion criteria, or had the following conditions: * Currently pregnant * Dysphasia (language deficiency) * Post-stroke neglect * Pacemaker implantation, * Involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb * The overall medical condition not suitable for the training (e.g., severe cardiac problem, unstable blood pressure, etc.).

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment (FMA) of the Upper Limb before the trainingFor each subject, the FMA score will be measured one day before the training.
Fugl-Meyer Assessment (FMA) of the Upper Limb after the trainingFor each subject, the FMA score will be measured one day after the 20-session training program.
Fugl-Meyer Assessment (FMA) of the Upper Limb 3-month follow-upFor each subject, the FMA score will be measured 3 months later after the last day of the training.

Secondary

MeasureTime frame
Modified Ashworth Scale (MAS)For each subject, the MAS score will be measure one day before the training, one day after the 20-session training program, and 3 months later after the last day of the training.
Action Research Arm Test (ARAT)For each subject, the ARAT score will be measure one day before the training, one day after the 20-session training program, and 3 months later after the last day of the training.

Countries

China

Contacts

CONTACTXiaoling Hu, PhD
xiaoling.hu@polyu.edu.hk34003206

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026